BRSK2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

BRSK2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 23 amino acids near the carboxy terminus of human BRSK2.

  Source: Synthetic

  (Accession #: Q8IWQ3)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: BRSK2
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-77281.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for BRSK2 Antibody Blocking Peptide

• BR serine/threonine kinase 2
• BR serine/threonine-protein kinase 2
• C11orf7
• chromsosome 11 open reading frame 7
• EC 2.7.11
• EC 2.7.11.1
• FLJ41362
• PEN11BSAD1
• protein kinase SAD1B
• serine/threonine kinase 29
• serine/threonine kinase SAD-A
• Serine/threonine-protein kinase 29
• Serine/threonine-protein kinase SAD-A
• STK29

Background

BRSK2 (BR serine/threonine-protein kinase 2) is required for the polarization of forebrain neurons which endows axons and dendrites with distinct properties, possibly by locally regulating phosphorylation of microtubule-associated proteins. This enyme is activated by phosphorylation on Thr-174 by STK11 in complex with STE20-related adapter-alpha (STRAD alpha) pseudo kinase and CAB39.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: BRSK2